Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.

Jillian Howlin, Helena Cirenajwis, Barbara Lettiero, Johan Staaf, Martin Lauss, Lao Saal, Ke Borg, Sofia Gruvberger, Göran B Jönsson

Research output: Contribution to journal › Article › peer-review

366 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours.'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology